NCT06590857 · Interventional trial
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Advanced Breast Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, ER+ Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Hormone-Sensitive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Metastatic Breast Cancer, Metastatic Breast Cancer With Bone Involvement
Delaware Valley sites
- Research Facility · Philadelphia, PA · Philadelphia County · Not yet recruiting
First posted
Registry updated
Added to the directory